Implications of infectious diseases and the adrenal hypothesis for the etiology of childhood acute lymphoblastic leukemia

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 3, 2010, Pages 226-229

  Azevedo Silva, F ^a   De Camargo, B ^a   Pombo de Oliveira, M S ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Adrenal hypothesis; Childhood infections; Epidemiology; Kala azar; Lymphoblastic leukemia

Indexed keywords

HYDROCORTISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BRAZIL; CANCER RISK; CHILDHOOD CANCER; DENGUE; ENVIRONMENTAL EXPOSURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHESIS; IMMUNE RESPONSE; INCIDENCE; INFECTION; LEISHMANIA CHAGASI; MALARIA; NOTE; PATHOGENESIS; RESPIRATORY TRACT DISEASE; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

NASO HEXACANTHUS;

EID: 77950180649     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500011     Document Type: Note

References (17)

1. Schmiegelow K, Vestergaard T, Nielsen SM, Hjalgrim H. Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis. Leukemia 2008; 22: 2137-2141.
2. Edgar K, Morgan A. Does infections cause or prevent childhood leukemia? A review of the scientific evidence. London: Children with Leukemia; 2008.
3. Gaynon PS, Carrel AL. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol 1999; 457: 593-605.
4. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193-203.
5. Hjalgrim LL, Rostgaard K, Schmiegelow K, Soderhall S, Kolmannskog S, Vettenranta K, et al. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 2003; 95: 1539-1544.
6. Rego EM, Garcia AB, Viana SR, Falcao RP. Characterization of acute lymphoblastic leukemia subtypes in Brazilian patients. Leuk Res 1996; 20: 349-355.
7. Pombo de Oliveira MS, Koifman S, Vasconcelos GM, Emerenciano M, de Oliveira NC. Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis 2009; 42: 121-125.
8. Bernaldez-Rios R, Ortega-Alvarez MC, Perez-Saldivar ML, Alatoma-Medina NE, Del Campo-Martinez ML, Rodriguez-Zepeda MC, et al. The age incidence of childhood B-cell precursor acute lymphoblastic leukemia in Mexico City. J Pediatr Hematol Oncol 2008; 30: 199-203.
9. de Camargo B, Santos MD, Rebelo MS, Reis RD, Ferman S, Noronha CP, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population-based cancer registries. Int J Cancer 2009; DOI 10.1002/ijc.24799.
10. Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer 1988; 42: 511-520.
11. Magalhaes IQ, Pombo-de-Oliveira MS, Bennett CA, Cordoba JC, Dobbin J, Ford AM, et al. TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 2000; 111: 204-207.
12. Reis RS, de Camargo B, Azevedo-Silva F, Ferreira JMO, Santos MO, Pombo-de-Oliveira MS. Childhood leukemia incidence in Brazil according to different geographical regions. Pediatric Blood and Cancer 2009 (in press).
13. Azevedo-Silva F, Reis RS, de Oliveira Santos M, Luiz RR, Pombo-de-Oliveira MS. Evaluation of childhood acute leukemia incidence and underreporting in Brazil by capture-recapture methodology. Cancer Epidemiol 2009; 33: 403-405.
14. Ribeiro KB, Buffler PA, Metayer C. Socioeconomic status and childhood acute lymphocytic leukemia incidence in São Paulo, Brazil. Int J Cancer 2008; 123: 1907-1912.
15. Holaday BJ, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa AQ, et al. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis 1993; 167: 411-417.
16. Jeronimo SM, Teixeira MJ, Sousa A, Thielking P, Pearson RD, Evans TG. Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin Infect Dis 2000; 30: 608-609.
17. Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005; 5: 420-426.